Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Cash from Financing Activities (2016 - 2025)

United Therapeutics' Cash from Financing Activities history spans 17 years, with the latest figure at $98.4 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 231.73% year-over-year to $98.4 million; the TTM value through Dec 2025 reached -$1.2 billion, up 8.35%, while the annual FY2025 figure was -$1.2 billion, 8.35% up from the prior year.
  • Cash from Financing Activities for Q4 2025 was $98.4 million at United Therapeutics, up from -$956.0 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $98.4 million in Q4 2025 and bottomed at -$1.1 billion in Q1 2024.
  • The 5-year median for Cash from Financing Activities is $7.2 million (2021), against an average of -$114.8 million.
  • The largest annual shift saw Cash from Financing Activities skyrocketed 640.0% in 2022 before it crashed 2297.53% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at $7.5 million in 2021, then surged by 640.0% to $55.5 million in 2022, then tumbled by 267.21% to -$92.8 million in 2023, then rose by 19.5% to -$74.7 million in 2024, then skyrocketed by 231.73% to $98.4 million in 2025.
  • Per Business Quant, the three most recent readings for UTHR's Cash from Financing Activities are $98.4 million (Q4 2025), -$956.0 million (Q3 2025), and -$198.6 million (Q2 2025).